Identification of targets for rational pharmacological therapy in childhood craniopharyngioma-Reference-Cited by-同舟云学术

Identification of targets for rational pharmacological therapy in childhood craniopharyngioma

Published:2015-05-21 Issue:1 Volume:3 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Gump Jacob M.,Donson Andrew M.,Birks Diane K.,Amani Vladimir M.,Rao Karun K.,Griesinger Andrea M.,Kleinschmidt-DeMasters B. K.,Johnston James M.,Anderson Richard C. E.,Rosenfeld Amy,Handler Michael,Gore Lia,Foreman Nicholas,Hankinson Todd C.

Funder

National Center for Advancing Translational Sciences

Morgan Adams Foundation

National Cancer Institute

American Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-015-0211-5.pdf

Reference49 articles.

1. Hankinson TC, Fields EC, Torok MR, Beaty BL, Handler MH, Foreman NK, O’Neill BR, Liu AK (2012) Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma. J Neurooncol 110(2):271–278. doi:10.1007/s11060-012-0966-5.

2. Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN (2012) Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol 14(8):1070–1078. doi10.1093/neuonc/nos142.

3. Muller HL (2014) Childhood craniopharyngioma: treatment strategies and outcomes. Expert Rev Neurother 14(2):187–197. doi:10.1586/14737175.2014.875470.

4. Kawamata T, Kubo O, Hori T (2005) Histological findings at the boundary of craniopharyngiomas. Brain Tumor Pathol 22(2):75–78. doi:10.1007/s10014-005-0191-4.

5. Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N, study committee of K (2010) Analyses of treatment variables for patients with childhood craniopharyngioma–results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr 73(3):175–180. doi:10.1159/000284358.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma;International Journal of Clinical Oncology;2024-08-30

2. Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma;Acta Neuropathologica Communications;2024-08-07

3. The clinical significance of inflammatory mediators in predicting obesity and progression-free survival in patients with adult-onset Craniopharyngioma;BMC Cancer;2024-07-04

4. Multiomics integration-based immunological characterizations of adamantinomatous craniopharyngioma in relation to keratinization;Cell Death & Disease;2024-06-21

5. Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis;PLOS ONE;2024-06-07